Press Release

April 24, 2023

Evonik obtains Certification for VISIOMER® Terra biobased methacrylates

The bio-content of VISIOMER® Terra methacrylate monomers is now certified by DIN CERTCO―the certification body of TÜV Rheinland Group―and will include the label “Certified Biobased Product.”

  • VISIOMER® Terra methacrylates independently certified by DIN CERTCO
  • Bio-content of up to 85 percent confirmed
  • Expanding portfolio of certified VISIOMER® Terra biobased methacrylate
    monomers as part of Evonik’s long-term climate mitigation strategy

Essen, Germany. The bio-content of VISIOMER® Terra methacrylate monomers is now certified by DIN CERTCO―the certification body of TÜV Rheinland Group―and will include the label “Certified Biobased Product.” DIN CERTCO certifies products using the C14 radiocarbon method and ASTM D 6866:2021 protocol instead of merely calculating the bio-content.

VISIOMER® Specialty Methacrylates are among the most versatile and efficient building blocks of macromolecular chemistry. They serve a broad range of industries and applications and enable individual and sustainable effects for products in adhesives, paints and coatings, among others. Evonik focuses on customized and innovative solutions for replacing hazardous or harmful substances, facilitating weight reduction in composites and reducing carbon footprint.

VISIOMER® Terra monomers contain up to 85 percent bio-content and must meet the highest performance requirements as well as have a low hazard potential. Expanding the portfolio of VISIOMER® Terra biobased monomers is part of Evonik’s long-term strategy to protect the environment and mitigate climate change without compromising performance.

In addition to DIN CERTCO certification, VISIOMER® Terra products are supported by detailed Life Cycle Assessments (LCAs) according to ISO 14040/14044. LCAs are a critical tool assessing various environmental impacts of VISIOMER® Terra Specialty Methacrylates throughout their production and support Evonik customers in benchmarking their own products.

“At Evonik we strive to minimize the environmental footprint of our own product while maximizing the handprint in the application. We are energized to develop products with superior sustainability benefits, so called next-generation solutions, in close collaboration with all partners along the value chain. For this purpose, we provide our customers with data from our Life Cycle Assessments”, says Alexander Kehl, Head of Specialty Methacrylates product line.

The portfolio of VISIOMER® Terra products is expanding and includes biobased equivalents of well-known monomers as well as new structures from readily available, biobased feedstocks. 

You can find the DIN CERTCO certificate of VISIOMER® Terra products here

For more information please visit www.visiomer.com

Visit us at the European Coatings Show from March 28-30 in Nuremberg. You can find us in hall 3C at booth 426. Dr. Christine Breiner will give a presentation on sustainable VISIOMER® Methacrylates, on Wednesday, March 29, 04:10 pm, in hall 3A at booth 607. For more information about Evonik at the ECS please visit: https://coatings.evonik.com/en

About Evonik

Evonik is one of the world leaders in specialty chemicals. The company is active in more than 100 countries around the world and generated sales of €15.3 billion and an operating profit (adjusted EBITDA) of €1.66 billion in 2023. Evonik goes far beyond chemistry to create innovative, profitable, and sustainable solutions for customers. About 32,000 employees work together for a common purpose: We want to improve life today and tomorrow.

About Specialty Additives

The Specialty Additives division combines the businesses of versatile additives and high-performance crosslinkers. They make end products more valuable, more durable, save more energy and simply better. As formulation experts in fast growing markets such as coatings, mobility, infrastructure and consumer goods, Specialty Additives combines a small amount with a big effect. With its 3,500 employees the division generated sales of €3.52 billion in 2023. 

Disclaimer

In so far as forecasts or expectations are expressed in this release or where our statements concern the future, these forecasts, expectations or statements may involve known or unknown risks and uncertainties. Actual results or developments may vary, depending on changes in the operating environment. Neither Evonik Industries AG nor its group companies assume an obligation to update the forecasts, expectations or statements contained in this release.